Your browser doesn't support javascript.
loading
FOXO1 Suppression is a Determinant of Acquired Lapatinib-Resistance in HER2-Positive Gastric Cancer Cells Through MET Upregulation.
Park, Jinju; Choi, Yiseul; Ko, Young San; Kim, Younghoon; Pyo, Jung-Soo; Jang, Bo Gun; Kim, Min A; Lee, Jae-Seon; Chang, Mee Soo; Park, Jong-Wan; Lee, Byung Lan.
Afiliación
  • Park J; Tumour Biology, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Choi Y; Tumour Biology, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Ko YS; Department of Forensic Medicine, National Forensic Service Busan Institute, Yangsan, Korea.
  • Kim Y; Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.
  • Pyo JS; Department of Pathology, Eulji University Hospital, Eulji University School of Medicine, Daejeon, Korea.
  • Jang BG; Department of Pathology, Jeju National University Hospital, Jeju, Korea.
  • Kim MA; Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.
  • Lee JS; Department of Molecular Medicine, Inha University College of Medicine, Incheon, Korea.
  • Chang MS; Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.
  • Park JW; Ischemic/Hypoxic Disease Institute Medical Research Center, Seoul National University College of Medicine, Seoul, Korea.
  • Lee BL; Tumour Biology, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Cancer Res Treat ; 50(1): 239-254, 2018 Jan.
Article en En | MEDLINE | ID: mdl-28343375

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Quinazolinas / Neoplasias Gástricas / Receptor ErbB-2 / Proteínas Proto-Oncogénicas c-met / Proteína Forkhead Box O1 / Antineoplásicos Límite: Humans Idioma: En Revista: Cancer Res Treat Año: 2018 Tipo del documento: Article Pais de publicación:

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Quinazolinas / Neoplasias Gástricas / Receptor ErbB-2 / Proteínas Proto-Oncogénicas c-met / Proteína Forkhead Box O1 / Antineoplásicos Límite: Humans Idioma: En Revista: Cancer Res Treat Año: 2018 Tipo del documento: Article Pais de publicación: